Case studyHow we are paid
PET-CT Second Read · commercial model

Profit-share, not retainer — so a bad quarter is our bad quarter.

The service earns from interpretation and from nothing else — no referral fee, no facilitation commission, no treatment pathway downstream that a report could be nudged toward. That is a revenue decision before it is an ethical one, and it costs money. It is also, consistently, the first thing patients cite when they explain why they chose this service over a hospital-based second opinion.

Pontem One conceived, designed, built and now operates the platform, compensated on profit-share rather than retainer. Our revenue moves with the number of patients the service actually reaches. Every schema fix, every published article and every page-speed regression has a direct line to our own P&L — and a bad quarter is our bad quarter, not just the client's.

72hPatient-facing turnaround
60hInternal deadline
4Continents served
0Treatment-side revenue

Profit-share needs measurable patient acquisition, end-to-end platform control, and a long horizon. Most practices have none of the three, and for them retainer or project pricing is the honest structure — we say so.

Curious whether your account could work this way?

It usually cannot, and we will tell you that in the first hour rather than the eighth month.

Request an audit